Laborie to Acquire JADA System from Organon

Simpson Thacher represented Laborie Medical Technologies Corp., a portfolio company of Patricia Industries, in its agreement to acquire the JADA System from Organon & Co. The transaction is valued at up to $465 million, comprised of $440 million payable at closing and a contingent milestone payment of up to $25 million subject to the achievement of certain 2026 revenue targets. The acquisition is expected to close in the first quarter of 2026, subject to customary closing conditions and regulatory approvals. The JADA System is an FDA‑cleared device designed for the rapid control and treatment of abnormal postpartum uterine bleeding or hemorrhage. The system has been launched in over 20 countries and is currently available in more than 2,000 hospitals across the United States. Headquartered in Portsmouth, New Hampshire, Laborie is a global medical technology company focused on Urology, Gastroenterology and Obstetrics, manufacturing diagnostic and therapeutic products. Patricia Industries is a long‑term owner that invests in companies and develops them to their full potential; it is part of Investor AB, whose principal owner is the Wallenberg Foundations. Simpson Thacher represented Laborie Medical Technologies Corp., a portfolio company of Patricia Industries, with a team composed by: Michael T. Holick, Keegan T. Lopez, Surya Banerjee, Felicity Bell, Margeaux Bergman and Madeline Moore (M&A); Jeannine McSweeney, Joshua Stephens and Shivani Motamarri (Executive Compensation & Employee Benefits); Vanessa Burrows, Alison Peters and Jacob Madden (Healthcare); Sophie Staples, Alec Jarvis, Andrew Mandelbaum and Benjamin Bressler (Tax); Benjamin Persina and Jackie Song (Credit); Caroline Geiger, Ron Ben‑Yehuda, Christina Breitbeil and Isabella Gonzalez (Intellectual Property); Karen Kazmerzak and Geoffrey Schmelkin (Antitrust); Krista McManus (Real Estate); and Timothy Mulvihill (Environmental).

Laborie to Acquire JADA System from Organon

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads